Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov page footer now shows revision v3.8.0 instead of v3.7.2. The study record information remains unchanged.SummaryDifference0.0%

- Check25 days agoChange DetectedA site-wide NIH banner announces the transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.SummaryDifference0.3%

- Check32 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check39 days agoChange DetectedThe website footer now identifies the site as running revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check53 days agoChange DetectedOn 2026-09-22, the study record was updated to Completed under Study Status, and Recruitment Status was adjusted accordingly. The previous status 'Active, not recruiting' was removed, and this entry is associated with version 89 released on 2026-08-26.SummaryDifference0.2%

- Check60 days agoChange DetectedAn additional revision marker, v3.7.0, is added and the previous marker, v3.6.6, is removed. This reflects an update to the history/versioning display on the page.SummaryDifference0.0%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.